GRAIL, Inc. Lease, Cost
GRAIL, Inc. (GRAL) reported Lease, Cost of $5.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- GRAIL, Inc. lease, cost for the quarter ending 2026-06-30 was $5.45M, a 0.76% increase year-over-year.
- GRAIL, Inc. lease, cost for the quarter ending 2025-12-31 was $5.43M, a 4.68% increase year-over-year.
- GRAIL, Inc. lease, cost for the quarter ending 2025-09-30 was $5.43M, a 4.52% decline year-over-year.
- GRAIL, Inc. lease, cost for the quarter ending 2025-06-30 was $5.41M.
- GRAIL, Inc. lease, cost for fiscal 2025 was $21.83M, a 6.09% decline from fiscal 2024.
- GRAIL, Inc. lease, cost for fiscal 2024 was $23.24M, a 17.09% decline from fiscal 2023.
- GRAIL, Inc. lease, cost for fiscal 2023 was $28.03M, a 7.27% increase from fiscal 2023.
- GRAIL, Inc. lease, cost for fiscal 2023 was $26.13M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.45M 10-Q · filed 2026-08-06 | $10.29M 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.86M derived: sum of 2 quarters · filed 2026-03-12 | $16.27M derived: sum of 3 quarters · filed 2026-08-06 | $21.83M 10-K · filed 2026-03-12 |
| 2025-09-30 | $5.43M 10-Q · filed 2025-11-13 | $10.84M derived: sum of 2 quarters · filed 2026-08-06 | $16.40M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.41M 10-Q · filed 2026-08-06 | $10.97M 10-Q · filed 2026-08-06 | ||
| 2024-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.88M derived: sum of 2 quarters · filed 2026-03-12 | $23.24M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $5.69M 10-Q · filed 2025-11-13 | $18.05M 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | $28.03M 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $26.13M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |